Evidence map›Paper›PMID 42449587›Full record

ReviewCancers2026

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Rita Ahmad, Motaz Almahmood, Rasha Kaddoura, Muhammad Ali Tariq, Ayman Abdullah Dalol, Marrita Rabadi, Aadhila Abbas Manthiri, Abdulrahman F Al-Mashdali, Hatem Ahmed, Mohammed Abdulgayoom and 4 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rita AhmadInternal Medicine, University of North Dakota, Fargo, ND 58104, USA.ORCID 0000-0002-8207-047X
Motaz AlmahmoodTower Health, Internal Medicine, Phoenixville, PA 19460, USA.ORCID 0009-0001-0577-7295
Rasha KaddouraPharmacy Department, Heart Hospital, Hamad Medical Corporation, Doha 3050, Qatar.
Muhammad Ali TariqTower Health, Internal Medicine, Phoenixville, PA 19460, USA.
Ayman Abdullah DalolCollege of Medicine, Qatar University, Doha 2713, Qatar.ORCID 0009-0000-7579-4923
Marrita RabadiCollege of Medicine, Qatar University, Doha 2713, Qatar.ORCID 0009-0009-8288-8368
Aadhila Abbas ManthiriCollege of Pharmacy, Qatar University, Doha 2713, Qatar.ORCID 0009-0008-0380-6364
Abdulrahman F Al-MashdaliHematology Department, National Center for Cancer Care and Research (NCCCR), Doha 3050, Qatar.
Hatem AhmedTower Health, Internal Medicine, Phoenixville, PA 19460, USA.
Mohammed AbdulgayoomHematology Department, National Center for Cancer Care and Research (NCCCR), Doha 3050, Qatar.ORCID 0000-0003-0622-8455
Ayah Al QaryouteSchool of Medicine, Appalachian State University, Boone, NC 28608, USA.
Sara WestallSchool of Medicine, University of North Dakota, Fargo, ND 58104, USA.
Fadi HaddadMD Anderson Cancer Center, Department of Leukemia, Houston, TX 77030, USA.ORCID 0000-0002-9702-8485
Shehab F MohamedHematology Department, National Center for Cancer Care and Research (NCCCR), Doha 3050, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ASXL1 mutationchronic myeloid leukemiaCMLTKIs

Identifiers

PMID42449587
PMCPMC13360061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.